Grace Century's stem cell bio-banking portfolio project Provia Laboratories has once again achieved record enrollments, with November company sales numbers increasing by a huge 66% compared to the same period last year. Provia have now exceeded their total 2014 enrollments by over 40% in 2015 year to date, with a full month of 2015 remaining.
Grace Century's Portfolio Project hits another all-time high for August 2015 enrollments, with August inquiries exceeding inquiries for the entire second half of 2014. The rapid growth is attributed to the increasing awareness of the potential benefits of storing stem cells for future use in personalized and regenerative medicine, as well as research developments and international expansion.
Grace Century has announced it is in advanced discussions with up to four new investment funds in the Asian market. This follows their exclusive selection and attendance at the MillionaireAsia seminar in Singapore on July 30th and further consolidates their growing presence and footprint in the Asian private equity market.
Market Research & Private Equity company Grace Century's bio banking project, Provia Laboratories, LLC has reported 47% quarterly growth in enrollments for their Store-a-tooth™ cryogenic storage service of dental stem cells. The impressive figure represents a highest-ever recorded growth rate in enrollments for the pioneering technology, which enables stem cell to to be stored for future therapeutic use.
Market Research & Private Equity company Grace Century, along with their partner Provia Laboratories LLC, have announced Provia's first ever patent. The newly patented technology will improve stored bio-specimen integrity for future use in research & diagnostic medicine, furthering the fields of bio-banking & personalized medicine.